Oracle (ORCL.N) launches an AI-powered cash management analytics tool for financial institutions.

Betta Pharmaceuticals said its pan‑RAS inhibitor BPI‑572270 capsule completed first‑participant dosing in an Australia Phase I/II study today. Preclinical data show strong inhibition in tumor cells and xenograft models with diverse RAS mutations (KRAS, NRAS, HRAS, including G12X, G13X, Q61X) across pancreatic, non‑small‑cell lung and colorectal cancers, and report favorable pharmacokinetics and safety.

英国央行副行长隆巴尔代利：劳动力市场招聘明显减少，但裁员并不多见。